{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:16:31Z","timestamp":1789168591478,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871243"],"award-info":[{"award-number":["81871243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the key research and development programs of Jiangsu Province","award":["BE2017697"],"award-info":[{"award-number":["BE2017697"]}]},{"name":"the Six Talent Peaks of Jiangsu Province","award":["WSN-009"],"award-info":[{"award-number":["WSN-009"]}]},{"name":"the Social Development Projects of Zhenjiang","award":["SH2018050"],"award-info":[{"award-number":["SH2018050"]}]},{"name":"\u201cLiuGeYi\u201d Projects of Jiangsu Province","award":["LGY2016055"],"award-info":[{"award-number":["LGY2016055"]}]},{"name":"the Affiliated Hospital of Jiangsu University","award":["jdfyRC2015010"],"award-info":[{"award-number":["jdfyRC2015010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Harnessing helminth-based immunoregulation is a novel therapeutic strategy for many immune dysfunction disorders, including inflammatory bowel diseases (IBDs). We previously identified a small molecule peptide from <jats:italic>Schistosoma japonicum<\/jats:italic> and named it SJMHE1. SJMHE1 can suppress delayed-type hypersensitivity, collagen-induced arthritis and asthma in mice. In this study, we assessed the effects of SJMHE1 on dextran sulfate sodium (DSS)-induced acute and chronic colitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Acute and chronic colitis were induced in C57BL\/6 mice by DSS, following which the mice were injected with an emulsifier SJMHE1 or phosphate-buffered saline. The mice were then examined for body weight loss, disease activity index, colon length, histopathological changes, cytokine expression and helper T (Th) cell subset distribution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SJMHE1 treatment significantly suppressed DSS-induced acute and chronic colitis, improved disease activity and pathological damage to the colon and modulated the expression of pro-inflammatory and anti-inflammatory cytokines in splenocytes and the colon. In addition, SJMHE1 treatment reduced the percentage of Th1 and Th17 cells and increased the percentage of Th2 and regulatory T (Treg) cells in the splenocytes and mesenteric lymph nodes of mice with acute colitis. Similarly, SJMHE1 treatment upregulated the expression of interleukin-10 (IL-10) mRNA, downregulated the expression of IL-17 mRNA and modulated the Th cell balance in mice with chronic colitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data show that SJMHE1 provided protection against acute and chronic colitis by restoring the immune balance. As a small molecule, SJMHE1 might be a novel agent for the treatment of IBDs without immunogenicity concerns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-021-04977-y","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T12:03:19Z","timestamp":1630929799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Schistosoma japonicum peptide SJMHE1 inhibits acute and chronic colitis induced by dextran sulfate sodium in mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Wenqi","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-6530","authenticated-orcid":false,"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"4977_CR1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/jcm9051273","volume":"9","author":"K Yeshi","year":"2020","unstructured":"Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products. J Clin Med. 2020;9:1273.","journal-title":"J Clin Med"},{"key":"4977_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MOG.0000000000000444","volume":"34","author":"JK Yamamoto-Furusho","year":"2018","unstructured":"Yamamoto-Furusho JK. Inflammatory bowel disease therapy: blockade of cytokines and cytokine signaling pathways. Curr Opin Gastroenterol. 2018;34:187\u201393.","journal-title":"Curr Opin Gastroenterol"},{"key":"4977_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/1744666X.2018.1532291","volume":"14","author":"A Fernandez-Clotet","year":"2018","unstructured":"Fernandez-Clotet A, Castro-Poceiro J, Panes J. Tofacitinib for the treatment of ulcerative colitis. Expert Rev Clin Immunol. 2018;14:881\u201392.","journal-title":"Expert Rev Clin Immunol"},{"key":"4977_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/00365521.2019.1591498","volume":"54","author":"JW Kim","year":"2019","unstructured":"Kim JW, Lee CK, Lee JK, Jeong SJ, Oh SJ, Moon JR, et al. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006\u20132015). Scand J Gastroenterol. 2019;54:419\u201326.","journal-title":"Scand J Gastroenterol"},{"key":"4977_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/jgh.14817","volume":"34","author":"JW Mak","year":"2019","unstructured":"Mak JW, Sung JJ. The use of biologics and biosimilar in Asian patients with IBD: are we ready? J Gastroenterol Hepatol. 2019;34:1269\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"4977_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000442922","volume":"34","author":"RW Leong","year":"2016","unstructured":"Leong RW, Mitrev N, Ko Y. Hygiene hypothesis: is the evidence the same all over the world? Dig Dis. 2016;34:35\u201342.","journal-title":"Dig Dis"},{"key":"4977_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pharmthera.2014.02.011","volume":"143","author":"M Heylen","year":"2014","unstructured":"Heylen M, Ruyssers NE, Gielis EM, Vanhomwegen E, Pelckmans PA, Moreels TG, et al. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease. Pharmacol Ther. 2014;143:153\u201367.","journal-title":"Pharmacol Ther"},{"key":"4977_CR8","doi-asserted-by":"publisher","first-page":"e1008508","DOI":"10.1371\/journal.ppat.1008508","volume":"16","author":"SM Ryan","year":"2020","unstructured":"Ryan SM, Eichenberger RM, Ruscher R, Giacomin PR, Loukas A. Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities. PLoS Pathog. 2020;16:e1008508.","journal-title":"PLoS Pathog."},{"key":"4977_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.arcmed.2019.03.001","volume":"50","author":"A Abdoli","year":"2019","unstructured":"Abdoli A. Therapeutic potential of helminths and helminth-derived antigens for resolution of inflammation in inflammatory bowel disease. Arch Med Res. 2019;50:58\u20139.","journal-title":"Arch Med Res"},{"key":"4977_CR10","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1096\/fj.99-0885hyp","volume":"14","author":"DE Elliott","year":"2000","unstructured":"Elliott DE, Urban JJ, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn\u2019s disease? FASEB J. 2000;14:1848\u201355.","journal-title":"FASEB J"},{"key":"4977_CR11","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.3748\/wjg.v17.i43.4810","volume":"17","author":"CM Xia","year":"2011","unstructured":"Xia CM, Zhao Y, Jiang L, Jiang J, Zhang SC. Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis. World J Gastroenterol. 2011;17:4810\u20136.","journal-title":"World J Gastroenterol"},{"key":"4977_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/gut.2004.041749","volume":"54","author":"RW Summers","year":"2005","unstructured":"Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn\u2019s disease. Gut. 2005;54:87\u201390.","journal-title":"Gut"},{"key":"4977_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ibd.20787","volume":"15","author":"NE Ruyssers","year":"2009","unstructured":"Ruyssers NE, De Winter BY, De Man JG, Loukas A, Pearson MS, Weinstock JV, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis. 2009;15:491\u2013500.","journal-title":"Inflamm Bowel Dis"},{"key":"4977_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13071-016-1434-4","volume":"9","author":"X Wang","year":"2016","unstructured":"Wang X, Wang J, Liang Y, Ni H, Shi L, Xu C, et al. Schistosoma japonicum HSP60-derived peptide SJMHE1 suppresses delayed-type hypersensitivity in a murine model. Parasit Vectors. 2016;9:147.","journal-title":"Parasit Vectors"},{"key":"4977_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jcmm.12991","volume":"21","author":"X Wang","year":"2017","unstructured":"Wang X, Li L, Wang J, Dong L, Shu Y, Liang Y, et al. Inhibition of cytokine response to TLR stimulation and alleviation of collagen-induced arthritis in mice by Schistosoma japonicum peptide SJMHE1. J Cell Mol Med. 2017;21:475\u201386.","journal-title":"J Cell Mol Med"},{"key":"4977_CR16","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1111\/jcmm.14661","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Li L, Zheng Y, Xue F, Yu M, Ma Y, et al. Schistosoma japonicum peptide SJMHE1 suppresses airway inflammation of allergic asthma in mice. J Cell Mol Med. 2019;23:7819\u201329.","journal-title":"J Cell Mol Med"},{"key":"4977_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2005.076000","volume":"55","author":"K Yoshihara","year":"2006","unstructured":"Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut. 2006;55:334\u201341.","journal-title":"Gut"},{"key":"4977_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/j.gastro.2007.11.004","volume":"134","author":"X Sun","year":"2008","unstructured":"Sun X, Somada S, Shibata K, Muta H, Yamada H, Yoshihara H, et al. A critical role of CD30 ligand\/CD30 in controlling inflammatory bowel diseases in mice. Gastroenterology. 2008;134:447\u201358.","journal-title":"Gastroenterology"},{"key":"4977_CR19","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.7150\/ijbs.43596","volume":"16","author":"F Xue","year":"2020","unstructured":"Xue F, Yu M, Li L, Zhang W, Ma Y, Dong L, et al. Elevated granulocytic myeloid-derived suppressor cells are closely related with elevation of Th17 cells in mice with experimental asthma. Int J Biol Sci. 2020;16:2072\u201383.","journal-title":"Int J Biol Sci"},{"key":"4977_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329\u201342.","journal-title":"Nat Rev Immunol"},{"key":"4977_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","volume":"17","author":"A Salas","year":"2020","unstructured":"Salas A, Hernandez-Rocha C, Duijvestein M, Faubion W, McGovern D, Vermeire S, et al. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:323\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4977_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/helm-2017-0048","volume":"55","author":"M Maruszewska-Cheruiyot","year":"2018","unstructured":"Maruszewska-Cheruiyot M, Donskow-Lysoniewska K, Doligalska M. Helminth therapy: advances in the use of parasitic worms against inflammatory bowel diseases and its challenges. Helminthologia. 2018;55:1\u201311.","journal-title":"Helminthologia"},{"key":"4977_CR23","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1007\/s10620-017-4655-2","volume":"62","author":"EK Boden","year":"2017","unstructured":"Boden EK, Lord JD. CD4 T Cells in IBD: crossing the line? Dig Dis Sci. 2017;62:2208\u201310.","journal-title":"Dig Dis Sci"},{"key":"4977_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/cells9010110","volume":"9","author":"I Tindemans","year":"2020","unstructured":"Tindemans I, Joosse ME, Samsom JN. Dissecting the heterogeneity in T-Cell mediated inflammation in IBD. Cells. 2020;9:110.","journal-title":"Cells"},{"key":"4977_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","volume":"128","author":"RW Summers","year":"2005","unstructured":"Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825\u201332.","journal-title":"Gastroenterology"},{"key":"4977_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/gut.2005.079129","volume":"55","author":"J Croese","year":"2006","unstructured":"Croese J, O\u2019Neil J, Masson J, Cooke S, Melrose W, Pritchard D, et al. A proof of concept study establishing Necator americanus in Crohn\u2019s patients and reservoir donors. Gut. 2006;55:136\u20137.","journal-title":"Gut"},{"key":"4977_CR27","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/ibd.21629","volume":"17","author":"GG Cancado","year":"2011","unstructured":"Cancado GG, Fiuza JA, de Paiva NC, Lemos Lde C, Ricci ND, Gazzinelli-Guimaraes PH, et al. Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB\/c mice. Inflamm Bowel Dis. 2011;17:2275\u201386.","journal-title":"Inflamm Bowel Dis"},{"key":"4977_CR28","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1038\/cti.2017.42","volume":"6","author":"IB Ferreira","year":"2017","unstructured":"Ferreira IB, Pickering DA, Troy S, Croese J, Loukas A, Navarro S. Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis. Clin Transl Immunology. 2017;6:e157.","journal-title":"Clin Transl Immunology."},{"key":"4977_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fimmu.2018.01016","volume":"9","author":"J Doonan","year":"2018","unstructured":"Doonan J, Lumb FE, Pineda MA, Tarafdar A, Crowe J, Khan AM, et al. Protection against arthritis by the parasitic worm product ES-62, and its drug-like small molecule analogues, is associated with inhibition of osteoclastogenesis. Front Immunol. 2018;9:1016.","journal-title":"Front Immunol"},{"key":"4977_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.actatropica.2018.05.015","volume":"185","author":"CJ Suckling","year":"2018","unstructured":"Suckling CJ, Mukherjee S, Khalaf AI, Narayan A, Scott FJ, Khare S, et al. Synthetic analogues of the parasitic worm product ES-62 reduce disease development in in vivo models of lung fibrosis. Acta Trop. 2018;185:212\u20138.","journal-title":"Acta Trop"},{"key":"4977_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imm.12860","volume":"154","author":"J Wang","year":"2018","unstructured":"Wang J, Goepfert C, Mueller N, Piersigilli A, Lin R, Wen H, et al. Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1\/type 17-mediated immune reactions. Immunology. 2018;154:76\u201388.","journal-title":"Immunology"},{"key":"4977_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/foods10010058","volume":"10","author":"JH Kim","year":"2020","unstructured":"Kim JH, Won YS, Cho HD, Hong SM, Moon KD, Seo KI. Protective effect of prunus mume fermented with mixed lactic acid bacteria in dextran sodium sulfate-induced colitis. Foods. 2020;10:58.","journal-title":"Foods"},{"key":"4977_CR33","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.7150\/thno.20359","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Xie H, Xu L, Liao Q, Wan S, Yu Z, et al. rSj16 Protects against DSS-induced colitis by inhibiting the PPAR-alpha signaling pathway. Theranostics. 2017;7:3446\u201360.","journal-title":"Theranostics"},{"key":"4977_CR34","doi-asserted-by":"publisher","first-page":"G385","DOI":"10.1152\/ajpgi.00049.2002","volume":"284","author":"DE Elliott","year":"2003","unstructured":"Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:G385\u201391.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4977_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13071-015-1288-1","volume":"9","author":"S Wang","year":"2016","unstructured":"Wang S, Xie Y, Yang X, Wang X, Yan K, Zhong Z, et al. Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice. Parasit Vectors. 2016;9:6.","journal-title":"Parasit Vectors"},{"key":"4977_CR36","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0016-5085(94)90803-6","volume":"107","author":"LA Dieleman","year":"1994","unstructured":"Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994;107:1643\u201352.","journal-title":"Gastroenterology"},{"key":"4977_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ibd.21779","volume":"18","author":"JB Brown","year":"2012","unstructured":"Brown JB, Cheresh P, Zhang Z, Ryu H, Managlia E, Barrett TA. P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm Bowel Dis. 2012;18:323\u201332.","journal-title":"Inflamm Bowel Dis"},{"key":"4977_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2008.09.019","volume":"377","author":"R Ito","year":"2008","unstructured":"Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R, et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun. 2008;377:12\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"4977_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijpara.2012.12.002","volume":"43","author":"AR Khan","year":"2013","unstructured":"Khan AR, Fallon PG. Helminth therapies: translating the unknown unknowns to known knowns. Int J Parasitol. 2013;43:293\u20139.","journal-title":"Int J Parasitol"},{"key":"4977_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000007822","volume":"62","author":"B Egger","year":"2000","unstructured":"Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 2000;62:240\u20138.","journal-title":"Digestion"},{"key":"4977_CR41","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238\u201349.","journal-title":"Lab Invest"},{"key":"4977_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","volume":"114","author":"LA Dieleman","year":"1998","unstructured":"Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385\u201391.","journal-title":"Clin Exp Immunol"},{"key":"4977_CR43","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s10753-019-01015-z","volume":"42","author":"YL Dong","year":"2019","unstructured":"Dong YL, Duan XY, Liu YJ, Fan H, Xu M, Chen QY, et al. Autotaxin-lysophosphatidic acid axis blockade improves inflammation by regulating Th17 cell differentiation in DSS-induced chronic colitis mice. Inflammation. 2019;42:1530\u201341.","journal-title":"Inflammation"},{"key":"4977_CR44","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/ibd\/izy107","volume":"24","author":"H Zhang","year":"2018","unstructured":"Zhang H, Dai Y, Liu Y, Wu T, Li J, Wang X, et al. Helicobacter pylori colonization protects against chronic experimental colitis by regulating Th17\/Treg balance. Inflamm Bowel Dis. 2018;24:1481\u201392.","journal-title":"Inflamm Bowel Dis"},{"key":"4977_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.molbiopara.2014.03.007","volume":"195","author":"W Harnett","year":"2014","unstructured":"Harnett W. Secretory products of helminth parasites as immunomodulators. Mol Biochem Parasitol. 2014;195:130\u20136.","journal-title":"Mol Biochem Parasitol"},{"key":"4977_CR46","doi-asserted-by":"publisher","first-page":"e1008391","DOI":"10.1371\/journal.ppat.1008391","volume":"16","author":"J Crowe","year":"2020","unstructured":"Crowe J, Lumb FE, Doonan J, Broussard M, Tarafdar A, Pineda MA, et al. The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing. PLoS Pathog. 2020;16:e1008391.","journal-title":"PLoS Pathog."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04977-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-021-04977-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04977-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:10:40Z","timestamp":1630933840000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-021-04977-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4977"],"URL":"https:\/\/doi.org\/10.1186\/s13071-021-04977-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As no human material was used, no ethical approval from human patients could be obtained. Animal experiments were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals and approved by the Animal Research Ethics Committee of Jiangsu University (UJS-LEAR-AP-2018030601).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}